Contact us


 

6D Tape Inc.

6D Tape Inc. is a Finnish health technology company founded in 2016. We focus on developing, marketing, and selling medical devices and products for physiotherapy, lymphatic therapy and active self-care. Our target indications for treatment are pain, scars, swelling and the sequelae of surgeries and trauma.

Our vision

We envision a world where advanced medical and therapeutical devices enhance the healing journey, enabling individuals to swiftly recover from surgeries, trauma, edema, swelling, pain and other health challenges.

Our mission

6D Tape is committed to pioneering innovative solutions that accelerate healing and enhance the quality of life.  Our dedication lies in offering accessible and affordable therapeutic solutions to everyone in need.

 

 

Our product portfolio includes the CE marked and patented 6D Tape products and the CE marked 6D Action vacuum therapy device.

6D Tape products
European Union: CE MDR 2017/745/EU: Class 1
USA: FDA Class 1, 510(K) Exempt, Product code KGX, Regulation # 21 CRF 880.5240, Listing # D442239

European Patent No. EP3528765

U.S. Patent No. 11,096,817

Japanese Patent No. 7007388

Canadian Patent No. 3,074,137

International patents pending.

6D Action vacuum therapy device
European Union: CE EN 60335-1:2012+A11:2014, EMC 2014/30/EU and LVD: 2014/35/EU
USA: FDA Class 1, 510(K) Exempt – Product code ISA, Regulation # 21 CRF 890.5660; Listing # D442242

 

Contact Us

Tapani Taskinen

CEO, Dr. (Tech)

Tel. +358 50 544 8444
tapani.taskinen@6daction.com

 

Jussi Karkela

 Sales Director, Physiotherapist

Tel.+358 44 276 3987
jussi.karkela@6daction.com

 

6D Tape

Sales & Logistics

Iso Kylätie 47
04130 Sipoo
Finland

Tel. +358 442763987
email.  6dtape@6daction.com

Company-ID and VAT-number: FI 27626265

6D Action -Service

Address:

Iso Kylätie 47
04130 Sipoo
Finland

Tel. +358 442763987
email. 6dtape@6daction.com

Please use this form to contact us.
We will get back to you as soon as possible.

  • This field is for validation purposes and should be left unchanged.